Reviews
Summary
Positives
- A Phoenix Rising forum member who tried multiple immunomodulators classified cyclosporin among the "strong effect" drugs they tested for ME/CFS-type illness Phoenix Rising.
- Patients with calcineurin-mediated autoimmune flares have shown response to low-dose cyclosporine-corticosteroid combinations with reduced rejection-equivalent inflammatory events Transplantation Research.
Negatives
- One severely ill patient reported "no response from the strongest (cyclosporin)" despite trying it as a last-resort immunosuppressant Phoenix Rising.
- Norwegian Fluge/Mella ME/CFS protocols explicitly excluded patients on prior calcineurin-class drugs like cyclosporine, suggesting limited mainstream uptake of this exact agent in the post-viral fatigue research community PMC.
Hurdles & Side Effects
- Patients face required serum-level monitoring, kidney-function tracking, and blood-pressure surveillance, making low-dose cyclosporine impractical outside specialist clinics Transplantation Research.
- A patient seeking the drug for ME/CFS or Long COVID would find no FDA-approved indication and almost no rheumatologists willing to prescribe off-label without an autoimmune diagnosis MEpedia.
Was this summary accurate?
Tell us how this treatment affected you
Patient reviews are the engine that keeps this page helpful. Whether you improved tremendously, got worse, or landed somewhere in between, your story helps someone with similar conditions make a more intelligent decision.
Find care